Formed from three specialist CDMOs, Bend Bioscience offers small-molecule capabilities and enabling technologies from pre-clinical through commercial scale, combining the breadth of a large CDMO with the flexibility and speed of an expert partner across a network of three specialized US facilities. The company offers accelerated solutions for orphan, breakthrough and specialty programs, along with tech transfer expertise to ease the transition from early development to commercial production.

댓글이 없습니다.
평가 & 댓글 남기기